Vifor Pharma Supports Iron Deficiency Day 2021: Call to Action for Early Diagnosis of Iron Deficiency | New

0


ST. GALLEN, Switzerland – (BUSINESS WIRE) – November 26, 2021–

Already for the seventh consecutive year of Iron Deficiency Day, Vifor Pharma is supporting a growing international alliance comprising the Heart Failure Policy Network, the European Kidney Health Alliance, Global Heart Hub and Croí the West of Ireland Cardiac Foundation with the aim to educate people about the importance of iron to the body and what can happen if iron levels are not properly managed. Iron Deficiency Day 2021 encourages people at risk to listen to their bodies, take iron seriously and take control of their health by seeking early diagnosis and medical help from their doctor.

Iron deficiency affects approximately half of patients with chronic kidney disease 2 and chronic heart failure and is associated with reduced quality of life 3, increased risk of hospitalization 4 and cardiovascular death 5. Despite serious consequences and the high prevalence of iron deficiency, the disease remains under-recognized. 6. The diagnosis and treatment of iron deficiency was further altered during the COVID-19 pandemic as patients faced limited access to healthcare, resulting in an even greater number of cases undiagnosed.

“We are delighted to join our partners in supporting Iron Deficiency Day 2021, at a time when pressures on health systems exacerbated by the pandemic mean that awareness of the importance of iron is more relevant than never, ”commented Abbas Hussain, CEO of Vifor Pharma. Group. “Together, we are committed to supporting people at risk and living with iron deficiency or iron deficiency anemia so that they can lead better, healthier lives.”

“COVID-19 has a significant impact on access to healthcare. With many healthcare systems facing significant backlogs, patients with symptoms of iron deficiency have been less likely to seek help from healthcare professionals. Said Dr Ewa Anita Jankowska, professor at Wroclaw Medical University, Poland. “However, iron deficiency is easily diagnosed and treatable. It is therefore essential to raise public awareness of this debilitating disease and ensure that individuals understand how to recognize symptoms and have access to early diagnosis and treatment options. “

To learn more about the importance of early diagnosis and recognition of symptoms of iron deficiency, visit www.takeironseriously.com/raise-awareness. Use the hashtags #TakeIronSeriously #IronDeficiency #IronDeficiencyDay and # IDDay2021 on Twitter and LinkedIn.

About the Vifor Pharma Group

The Vifor Pharma Group is a global pharmaceutical company. It aims to become the world leader in iron deficiency, nephrology and cardio-renal therapies. The company is a partner of choice for pharmaceuticals and innovative patient-centric solutions. The Vifor Pharma Group strives to help patients around the world with severe and chronic illnesses lead better and healthier lives. The company develops, manufactures and markets pharmaceutical products for precision patient care. The Vifor Pharma Group occupies a leading position in all of its main activities and consists of the following companies: Vifor Pharma and Vifor Fresenius Medical Care Renal Pharma (a joint company with Fresenius Medical Care). The Vifor Pharma group is headquartered in Switzerland and is listed on the Swiss Stock Exchange (SIX Swiss Exchange, VIFN, ISIN: CH0364749348).

For more information, please visit viveorpharma.com.

Notes to Editors

Takeironseriously.com is intended to provide educational information to an international audience outside of the United States; it is available in 12 languages. All information on the site is for educational purposes only and should not be used as a substitute for discussion with a healthcare professional. All decisions about patient care should be made by a healthcare professional and be made based on the unique needs of each patient.

About iron deficiency

Iron plays a vital role in many bodily processes, including the production of red blood cells, the efficient functioning of the heart and brain, and the prevention of infection and disease. Without enough iron, the body is unable to function properly. Common symptoms include fatigue, dizziness, and shortness of breath. Iron deficiency and iron deficiency anemia are estimated to affect one in three people worldwide 7, but despite the serious consequences and high prevalence 8, it remains an underestimated disease.

Although iron deficiency can affect anyone, it is more common in premenopausal women, pregnant women and children under the age of five.9 If left untreated, it can progress to iron deficiency anemia. The effects of iron deficiency differ from person to person, but may be linked to a general decline in general health and well-being.10 Even without anemia, iron deficiency can be debilitating , exacerbate an underlying chronic disease and lead to increased morbidity and mortality 11 Common symptoms include fatigue 10, 12, 13 pale skin 12, brittle nails 12, 14, craving for non-food items such as dirt, clay and ice 15 and inability to concentrate 10, 16. In children, iron deficiency can significantly affect cognitive and motor development 17.

The references

1. Hassan, Tamer Hasan et al. “Impact of iron deficiency anemia on immune system function in children.” »Ed. Esaki M. Shankar. Medicine 95.47 (2016): e5395. PMC. The Web. June 12, 2018.

2. Wong MMY et al. Clin Kid J 2019: 1-12; Rocha BML, et al. J Am Coll Cardiol. 2018; 71 (7): 782-793.

3. Guedes M END 2021. doi: 10.1093 / ndt / gfab050; Enjuanes C, et al. Int J Cardiol. 2014; 174 (2): 268-275.

4. Guedes et al. J Am Soc Nephrol. Aug 2021; 32 (8): 2020-2030, Martens P, et al. Acta Cardiol. 2018; 73 (2): 115–123.

5. Guedes et al. J Am Soc Nephrol. August 2021; 32 (8): 2020-2030; Klip IT, et al. Am Heart J. 2013; 165: 575–82.e3.

6. Eur J Heart Fail. 2021 Sep doi: 10.1002 / ejhf.2338.

7. Peyrin-Biroulet L, et al. Guidelines for the diagnosis and treatment of iron deficiency in all indications: a systematic review. Am J Clin Nutr. 2015; 102 (6): 1585-94.

8. World Health Organization. Global prevalence of anemia 1993-2005. 2008. Available at URL: http://apps.who.int/iris/bitstream/handle/10665/43894/9789241596657—eng.pdf;jsessionid=9C613E2F4D481EDEB9DE07986AFC E0C7? Sequence = 1. Last consulted: June 2018.

9. Hercberg S, et al. Iron deficiency in Europe. Nutr Public Health. 2007; 4 (2b).

10. Fernando B, et al. A guide to the diagnosis of iron deficiency and iron deficiency anemia in digestive diseases. World J Gastroenterol. October 7, 2009; 15 (37): 4638-4643.

11. Cappellini MD et al. Iron deficiency in chronic inflammatory diseases: international expert advice on definition, diagnosis and management. Am J Hematol. October 2017; 92 (10): 1068-1078.

12. Auerbach M, Adamson JW. How we diagnose and treat iron deficiency anemia. Am J Hematol. 2016; 91 (1): 31-38.

13. Favrat, B., et al. (2014). Evaluation of a single dose of ferric carboxymaltose in tired, iron-deficient women – PREFER a randomized, placebo-controlled study. PLoS A 9 (4): e94217. Electronic collection 2014.

14. Cashman MW, Sloan SB. Nutrition and nail disease. Clin Dermatol. 2010; 28 (4): 420-5.

15. Barton JC, et al. Pica associated with iron deficiency or depletion: clinical and biological correlates in 262 non-pregnant adult ambulatory patients. BMC blood disorder. 2010; 10: 9. doi: 10.1186 / 1471-2326-10-9.

16. Patterson A et al. Iron Deficiency, General Health, and Fatigue: Findings from the Australian Longitudinal Women’s Health Study. Qual Life Res. 2000; 9: 491-497.

17. World Health Organization. Nutritional anemias: tools for effective prevention and control. 2017. Available at URL: http://www.who.int/nutrition/publications/micronutrients/anemias-tools-prevention-control/en/. Last consulted: June 2018.

View source version on businesswire.com:https://www.businesswire.com/news/home/2021112506152/en/

CONTACT: Contact and additional information:

Media relations

Nathalie Ponnier

Global Head of Corporate Communications

+41 79 957 96 73

[email protected]

KEYWORD: SWITZERLAND EUROPE

INDUSTRY KEYWORD: HEALTH HEALTH OTHER HEALTH CARE MANAGED BY PHARMACEUTICAL HEALTH BIOTECHNOLOGY

SOURCE: Vifor Pharma

Copyright Business Wire 2021.

PUB: 11/26/2021 1:00 a.m. / DISC: 11/26/2021 1:02 a.m.

http://www.businesswire.com/news/home/2021112506152/en


Share.

Comments are closed.